Medtronic logo

MDT - Medtronic Share Price

$125.91 0.1  0.0%

Last Trade - 16/04/21

Large Cap
Market Cap £122.73bn
Enterprise Value £134.19bn
Revenue £20.19bn
Position in Universe 63rd / 6850
Unlock MDT Revenue
Relative Strength (%)
1m -0.29%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.73%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 24th Apr 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
20,261 28,833 29,710 29,953 30,557 28,913 29,985 32,538 +7.4%
-23.0 -4.6 +21.6 +11.3 +12.8 -4.2 +5.05 +31.8
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 29 January 2021, MedtronicPLC revenues decreased 4% to $21.93B. Net income beforeextraordinary items decreased 45% to $2.25B. Revenuesreflect Cardiac and vascular Group segment decrease of 7%to $7.86B, Restorative Therapies Group segment decrease of5% to $5.9B, United States segment decrease of 6% to$11.34B, Rest of World segment decrease of 3% to $10.51B.Net income also reflects Restructuring charges.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MDT
Graphical History


MDT Revenue Unlock MDT Revenue

Net Income

MDT Net Income Unlock MDT Revenue

Normalised EPS

MDT Normalised EPS Unlock MDT Revenue

PE Ratio Range

MDT PE Ratio Range Unlock MDT Revenue

Dividend Yield Range

MDT Dividend Yield Range Unlock MDT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MDT EPS Forecasts Unlock MDT Revenue
Profile Summary

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Last Annual April 24th, 2020
Last Interim January 29th, 2021
Incorporated June 12, 2014
Public Since March 17, 1980
No. of Shareholders: 24,933
No. of Employees: 90,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,348,072,847
Free Float (0.0%)
Eligible for
MDT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MDT
Upcoming Events for MDT
Thursday 27th May, 2021
Q4 2021 Medtronic PLC Earnings Call
Thursday 27th May, 2021
Q4 2021 Medtronic PLC Earnings Release
Tuesday 24th August, 2021
Q1 2022 Medtronic PLC Earnings Call
Tuesday 24th August, 2021
Q1 2022 Medtronic PLC Earnings Release
Frequently Asked Questions for Medtronic
What is the Medtronic share price?

As of 16/04/21, shares in Medtronic are trading at $125.91, giving the company a market capitalisation of £122.73bn. This share price information is delayed by 15 minutes.

How has the Medtronic share price performed this year?

Shares in Medtronic are currently trading at $125.91 and the price has moved by 31.57% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medtronic price has moved by -9.31% over the past year.

What are the analyst and broker recommendations for Medtronic?

Of the analysts with advisory recommendations for Medtronic, there are there are currently 8 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medtronic is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Medtronic next release its financial results?

Medtronic is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-29
What is the Medtronic dividend yield?

The Medtronic dividend yield is 1.81% based on the trailing twelve month period.

Does Medtronic pay a dividend?

Last year, Medtronic paid a total dividend of 2.28, and it currently has a trailing dividend yield of 1.81%. Looking ahead, Medtronic has not announced an ex-dividend date yet.

When does Medtronic next pay dividends?

Medtronic has yet to annouce their ex-dividend date. The historic dividend yield on Medtronic shares is currently 1.81%.

How do I buy Medtronic shares?

To buy shares in Medtronic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medtronic?

Shares in Medtronic are currently trading at $125.91, giving the company a market capitalisation of £122.73bn.

Where are Medtronic shares listed? Where are Medtronic shares listed?

Here are the trading details for Medtronic:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: MDT
What kind of share is Medtronic?

Based on an overall assessment of its quality, value and momentum, Medtronic is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medtronic share price forecast 2021?

Shares in Medtronic are currently priced at $125.91. At that level they are trading at 6.52% discount to the analyst consensus target price of 0.00.

Analysts covering Medtronic currently have a consensus Earnings Per Share (EPS) forecast of 4.34 for the next financial year.

How can I tell whether the Medtronic share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medtronic. Over the past six months, the relative strength of its shares against the market has been -6.05%. At the current price of $125.91, shares in Medtronic are trading at 14.64% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medtronic PE Ratio?

The Medtronic PE ratio based on its reported earnings over the past 12 months is 44.96. The shares are currently trading at $125.91.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medtronic?

Medtronic's management team is headed by:

Richard Anderson - IND
Richard Kuntz - SVP
Scott Donnelly - IND
Geoffrey Martha - CHM
Bradley Lerman - SVP
Carol Surface - CHO
Robert ten Hoedt - EVP
Craig Arnold - IND
Randall Hogan - IND
Karen Parkhill - CFO
Robert White - EVP
Andrea Goldsmith - IND
John Liddicoat - EVP
Sean Salmon - EVP
Brett Wall - EVP
Who are the major shareholders of Medtronic?

Here are the top five shareholders of Medtronic based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.26% (111.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.08% (68.5m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.15% (55.9m shares)
MFS Investment Management Investment Advisor/Hedge Fund
Percentage owned: 3.6% (48.5m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 2.87% (38.6m shares)
Similar to MDT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.